Trump diagnosed with vein condition causing leg swelling: White House
White House spokesperson Karoline Leavitt, reading a letter from Trump's doctor at a press briefing, said both ailments were benign. His leg swelling is from a 'common' vein condition, and his hand is bruised from shaking so many hands, she told reporters.
The disclosure sought to put to rest a raft of Internet rumours that the 79-year-old Trump might be suffering from a serious ailment based on the photographic evidence.
After Leavitt's briefing, the White House released the letter from a US Navy officer who is Trump's physician, Sean Barbabella. It said Trump underwent a suite of tests about the issues.
Barbabella said an ultrasound on the president's legs 'revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70'.
The letter said there was no evidence that Trump had contracted deep vein thrombosis or arterial disease.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Additional exams identified no signs of heart failure, kidney impairment, or a systemic illness, Barbabella said.
Leavitt told reporters Trump was not experiencing discomfort due to the condition.
Barbabella also said that Trump had bruising on the back of his right hand.
He described this as 'consistent with minor soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen'.
'President Trump remains in excellent health,' he said.
Kwame Amankwah, a physician who is chief of vascular surgery at the University of Connecticut in Hartford, said chronic venous insufficiency is usually an issue with the lower legs in which the veins have problems sending blood from the legs back to the heart.
It is usually treated with compression stockings and leg elevation, he said.
'Even if he doesn't have heart disease, the condition needs to be addressed. If it's not managed with compression stockings and elevation, severe swelling and ulcers can develop, warranting more significant medical interventions,' Amankwah said.
Todd Berland, a physician who is director of outpatient vascular interventions at NYU Langone Health, said chronic venous insufficiency 'has no overall effect on life expectancy. It's a quality-of-life issue, not a quantity of life issue'.
Trump underwent an extensive physical examination on Apr 11 at Walter Reed National Military Medical Center in suburban Washington. It said Trump had a normal heart rhythm and no major health problems. REUTERS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
International Business Times
3 days ago
- International Business Times
Trump Demands Drug Price Cuts in Letters to 17 Pharma Giants Summary
US President Donald Trump has sent letters to 17 major pharmaceutical companies demanding they cut prescription drug prices in the United States. The letters, released Thursday by the White House, outline his plan to match U.S. prices with those in other developed countries. President Donald Trump addessses the nation after U.S. bombed Iran's nuclear facilities X Trump recently signed an executive order requiring drugmakers to offer "most-favored-nation" pricing. This means companies must sell medications to U.S. patients at the lowest price they offer elsewhere. If drug companies do not comply, Trump warned the government could import cheaper alternatives or take other steps. Companies that received the letters include Pfizer, Eli Lilly, Johnson & Johnson, Merck, Sanofi, and AstraZeneca. Trump had previously criticized earlier proposals from the industry, saying they prioritized profits over patient care. He also demanded that drugmakers return any excess profits made by raising prices overseas to compensate American taxpayers. Shares of major pharmaceutical firms fell after the announcement. Pfizer, Eli Lilly, and Gilead each dropped by around 2%, while a broader index of drug stocks declined 3%. Trump also suggested a system where companies can sell drugs directly to patients, bypassing middlemen, but only if they agree to international pricing rules. The president gave drugmakers a deadline of September 29 to respond with binding commitments. Health experts are skeptical that companies will meet Trump's demands. Some analysts believe the proposals are unlikely to result in immediate price changes, describing them as more political pressure than enforceable policy. Still, several companies, including Pfizer and Novartis, said they are open to working with the administration. Pfizer confirmed its ongoing talks with Trump officials to improve access and affordability for U.S. patients. U.S. drug prices remain among the highest in the world, with patients often paying nearly three times more than those in other developed countries. Drugmakers argue that sharp price cuts could harm innovation, but Trump insists bold action is needed to protect Americans from high costs.
Straits Times
3 days ago
- Straits Times
US plans Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
Sign up now: Get ST's newsletters delivered to your inbox GLP-1 drugs have gained popularity for their ability to reduce body weight by suppressing appetite and slowing digestion. WASHINGTON - The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Aug 1, citing documents from the Centers for Medicare and Medicaid Services. GLP-1 drugs, originally developed for type 2 diabetes, have gained popularity for their ability to reduce body weight by suppressing appetite and slowing digestion. But their high cost – typically between US$5,000 (S$6,490) and US$7,000 per year – has raised concerns about long-term affordability. The proposed plan would permit state Medicaid programs and Medicare Part D insurance plans to voluntarily cover GLP-1 drugs, including those from market leaders Novo Nordisk and Eli Lilly, the report said. Lilly and Novo are leaders in the weight-loss drug market, which some analysts expect could bring in more than US$150 billion in revenues by the next decade. Lilly's shares were up nearly 2 per cent in premarket trading. The initiative is slated to begin in April 2026 for Medicaid and January 2027 for Medicare. If it clears the way, it would mark a shift in federal policy after the administration said earlier this year that the programs would not cover weight loss drugs. A proposal under the Biden administration had also aimed to expand access to the medications. The Centres for Medicare & Medicaid Services, Lilly and Novo did not immediately respond to a Reuters request for comment. REUTERS
Straits Times
3 days ago
- Straits Times
BridgePoint Health awarded tender for Bidadari clinic with $18,000 rental
Sign up now: Get ST's newsletters delivered to your inbox A staggered rent structure will be implemented to help tenants of newly-constructed shops in new estates. SINGAPORE - Bridgepoint Health has been awarded the tender for a General Practitioner (GP) clinic at the newly completed Bartley Beacon, a Build-To-Order (BTO) project in Bidadari. In a joint statement on Aug 1, the Ministry of Health (MOH) and Housing & Development Board (HDB) said the tender was awarded under the new Price-Quality Method (PQM), where tenders are evaluated based on both price and quality factors. Bridgepoint Health's care teams consist of family physicians, administrators, other health professionals, and specialists. It works with Northeast Medical Group, with a total of 20 clinics planned and in operation island-wide. A total of 18 bids were received for the tender which opened on May 8 2025 and closed on May 29. Under the pilot, the tender price – or the rental bid – accounted for 30 per cent of the scoring criteria, and was evaluated by HDB. The quality of the tender proposal accounted for the remaining 70 per cent, and was assessed by MOH. The awarded monthly rent is $18,000 for the clinic space of about 100sqm, which is twice the size of a typical clinic. The cost per square metre is $180, lower than the average awarded bid of $382 per sqm for GP clinic tenders awarded in new housing projects in the last three years, said MOH and HDB. This comes after the monthly rental bid for a GP clinic in Tampines was reported at $52,188 for a 52sqm ground-floor unit, bringing the cost per square metre to about $1,003.60, in early June. Top stories Swipe. Select. Stay informed. Tech Reporting suspected advanced cyber attacks will provide a defence framework: Shanmugam Singapore Tanjong Katong sinkhole: Road will progressively open to motorists from Aug 2 noon World Trump modifies reciprocal tariffs ahead of deadline; rate on Singapore likely to remain at 10% Business Singapore's US tariff rate stays at 10%, but the Republic is not out of the woods yet Singapore NUS launches S'pore's first nursing practice doctorate to meet evolving healthcare needs Singapore Data breach involving 147,000 Cycle & Carriage Singapore customer records under probe Business CAD probing Tokenize Xchange operator; firm's director charged with fraudulent trading Singapore PM Wong to deliver National Day message on Aug 8 Then, Health Minister Ong Ye Kung expressed his dismay at the bid , and said that the monthly rental for the clinic would translate into higher healthcare costs one way or other, and negate MOH's efforts to keep the cost of primary healthcare affordable. He also noted that higher rental bids do not necessarily translate to the best healthcare that the community needs. Bridgepoint Health will have to be onboarded by Healthier SG as part of the Primary Care Network, and will have to be Community Health Assist Scheme (CHAS) accredited. Additionally, the clinic will have to refrain from providing aesthetic services and instead focus solely on providing primary care services, said MOH and HDB. The clinic will also be able to provide basic ancillary services such as Diabetic Retinal Photography (DRP), Diabetic Foot Screening (DFS), and nurse counselling for diabetic patients. It will remain part of the Mental Health General Practitioner Partnership (MHGPP) and manage patients with more complex mental health conditions, while offering most of their services onsite to reduce the need for referrals. Three more GP clinic tenders are to be launched under the pilot PQM framework in 2025. The next PQM tender will be launched at Costa Grove, a BTO project in Pasir Ris. Another two PQM tenders, at Parc Point and Toh Guan Grove, will be launched by the end of 2025. To help tenants of newly-constructed shops in new estates, HDB has a staggered rent structure in place over the first three-year tenancy term, said the statement. Tenants will be required to pay 80 per cent of tendered rent in the first year, 90 per cent in the second year, and the full tendered rent in the third year.
